 <h1>Axicabtagene ciloleucel Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to axicabtagene ciloleucel: intravenous suspension</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Suspension)</p><p>Cytokine release syndrome and neurologic toxicitiesCytokine Release Syndrome (CRS), including fatal or life-threatening reactions, occurred in patients receiving axicabtagene ciloleucel. Do not administer axicabtagene ciloleucel to patients with active infection or inflammatory disorders. Treat severe or life-threatening CRS with tocilizumab or tocilizumab and corticosteroids.Neurologic toxicities, including fatal or life-threatening reactions, occurred in patients receiving axicabtagene ciloleucel, including concurrently with CRS or after CRS resolution. Monitor for neurologic toxicities after treatment with axicabtagene ciloleucel. Provide supportive care and/or corticosteroids as needed.Axicabtagene ciloleucel is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the YESCARTA(TM) REMS.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, axicabtagene ciloleucel may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking axicabtagene ciloleucel:</p><p>
<i>More common</i>
</p><ul>
<li>Agitation</li>
<li>back pain</li>
<li>bloody urine</li>
<li>blue lips and fingernails</li>
<li>blurred vision</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>confusion as to time, place, or person</li>
<li>cough</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>decreased frequency or amount of urine</li>
<li>diarrhea</li>
<li>difficult, fast, noisy breathing</li>
<li>dilated neck veins</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>extreme tiredness or weakness</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>hoarseness</li>
<li>holding false beliefs that cannot be changed by fact</li>
<li>increase in heart rate</li>
<li>increased blood pressure</li>
<li>increased sweating</li>
<li>increased thirst</li>
<li>irregular breathing</li>
<li>irritability</li>
<li>lightheadedness</li>
<li>loss of appetite</li>
<li>loss of consciousness</li>
<li>lower back or side pain</li>
<li>mood or mental changes</li>
<li>muscle or joint pain</li>
<li>nausea</li>
<li>nervousness</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>problems with speech or speaking</li>
<li>rapid breathing</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>seizures</li>
<li>shakiness and unsteady walk</li>
<li>slow heartbeat</li>
<li>stiff neck</li>
<li>sunken eyes</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area</li>
<li>thirst</li>
<li>tightness in the chest</li>
<li>trembling or shaking of the hands or feet</li>
<li>troubled breathing</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>unusual excitement, nervousness, or restlessness</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>weight gain</li>
<li>wrinkled skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Cloudy urine</li>
<li>muscle twitching or jerking</li>
<li>rhythmic movement of the muscles</li>
<li>stomach pain</li>
<li>unusual bleeding or bruising</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of axicabtagene ciloleucel may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
<li>decreased appetite and weight</li>
<li>difficulty in moving</li>
<li>muscle stiffness</li>
<li>pain in the joints, arms or legs</li>
</ul><p>
<!-- end intravenous suspension --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to axicabtagene ciloleucel: intravenous suspension</i></p><h3>General</h3><p>The most common adverse reactions (reported incidence of 30% or greater) include lymphopenia, leukopenia, cytokine release syndrome, neutropenia, fever, anemia, thrombocytopenia, encephalopathy, hypotension, tachycardia, fatigue, headache, decreased appetite, chills, diarrhea, nausea, hypoxia, tremor, and cough.</p>
<p></p>
<p>In the event of a manufacturing failure (1% in clinical trials), a second manufacturing of this drug may be attempted; while the patient awaits the product, additional chemotherapy (not the lymphodepletion) may be necessary and may increase the risk of adverse events during the pre-infusion period.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphopenia (100%), leukopenia (96%), neutropenia (93%), anemia (66%), thrombocytopenia (58%), febrile neutropenia (36%)</p>
<p><b>Common</b> (1% to 10%): Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), coagulopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fever (86%), fatigue (46%), chills (40%), infections-pathogen unspecified (26%), edema (19%), viral infections (16%), bacterial infections (13%)</p>
<p><b>Common</b> (1% to 10%): Fungal infections<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypotension (57%), tachycardia (57%), arrhythmia (23%), hypertension (15%), thrombosis (10%)</p>
<p><b>Common</b> (1% to 10%): Cardiac failure, cardiac arrest, capillary leak syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Encephalopathy (57%), headache (45%), tremor (31%), dizziness (21%), aphasia (18%)</p>
<p><b>Common</b> (1% to 10%): Ataxia, seizure, dyscalculia, myoclonus, neuropathy, seizure, dysphasia</p>
<p><b>Frequency not reported</b>: Leukoencephalopathy, cerebral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Spinal cord edema, myelitis, quadriplegia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypophosphatemia (50%), decreased appetite (44%), hyponatremia (19%), decreased weight (16%), increased uric acid (13%), dehydration (11%), hypokalemia (10%)</p>
<p><b>Common</b> (1% to 10%): Hypocalcemia, hypoalbuminemia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (38%), nausea (34%), vomiting (26%), constipation (23%), abdominal pain (14%), dry mouth (11%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Hypoxia (32%), cough (30%), dyspnea (19%), pleural effusion (13%)</p>
<p><b>Common</b> (1% to 10%): Pulmonary edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Motor dysfunction (19%), pain in extremity (17%), back pain (15%), muscle pain (14%), arthralgia (10%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Delirium (17%), anxiety</p>
<p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increased direct bilirubin (13%), increased ALT (10%)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Renal insufficiency (12%)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity reaction<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Cytokine release syndrome (94%), hypogammaglobulinemia (15%), unspecified pathogen infections, viral infections, bacterial infections, histiocytosis hematophagic</p>
<p><b>Common</b> (1% to 10%): Fungal infections<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Yescarta (axicabtagene ciloleucel)." Kite Pharma, Inc., El Segundo, CA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the cost of Yescarta?</li>
<li>How is Yescarta administered?</li>
<li>What type of drug is Yescarta (axicabtagene ciloleucel)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about axicabtagene ciloleucel</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Axicabtagene ciloleucel Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Yescarta</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>B Cell Lymphoma</li>
<li>Diffuse Large B-Cell Lymphoma</li>
<li>Follicular Lymphoma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to axicabtagene ciloleucel: intravenous suspension</i></p><h3>General</h3><p>The most common adverse reactions (reported incidence of 30% or greater) include lymphopenia, leukopenia, cytokine release syndrome, neutropenia, fever, anemia, thrombocytopenia, encephalopathy, hypotension, tachycardia, fatigue, headache, decreased appetite, chills, diarrhea, nausea, hypoxia, tremor, and cough.</p><p></p><p>In the event of a manufacturing failure (1% in clinical trials), a second manufacturing of this drug may be attempted; while the patient awaits the product, additional chemotherapy (not the lymphodepletion) may be necessary and may increase the risk of adverse events during the pre-infusion period.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphopenia (100%), leukopenia (96%), neutropenia (93%), anemia (66%), thrombocytopenia (58%), febrile neutropenia (36%)</p><p><b>Common</b> (1% to 10%): Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), coagulopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fever (86%), fatigue (46%), chills (40%), infections-pathogen unspecified (26%), edema (19%), viral infections (16%), bacterial infections (13%)</p><p><b>Common</b> (1% to 10%): Fungal infections<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypotension (57%), tachycardia (57%), arrhythmia (23%), hypertension (15%), thrombosis (10%)</p><p><b>Common</b> (1% to 10%): Cardiac failure, cardiac arrest, capillary leak syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Encephalopathy (57%), headache (45%), tremor (31%), dizziness (21%), aphasia (18%)</p><p><b>Common</b> (1% to 10%): Ataxia, seizure, dyscalculia, myoclonus, neuropathy, seizure, dysphasia</p><p><b>Frequency not reported</b>: Leukoencephalopathy, cerebral edema</p><p><b>Uncommon</b> (0.1% to 1%): Spinal cord edema, myelitis, quadriplegia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypophosphatemia (50%), decreased appetite (44%), hyponatremia (19%), decreased weight (16%), increased uric acid (13%), dehydration (11%), hypokalemia (10%)</p><p><b>Common</b> (1% to 10%): Hypocalcemia, hypoalbuminemia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (38%), nausea (34%), vomiting (26%), constipation (23%), abdominal pain (14%), dry mouth (11%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Hypoxia (32%), cough (30%), dyspnea (19%), pleural effusion (13%)</p><p><b>Common</b> (1% to 10%): Pulmonary edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Motor dysfunction (19%), pain in extremity (17%), back pain (15%), muscle pain (14%), arthralgia (10%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Delirium (17%), anxiety</p><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increased direct bilirubin (13%), increased ALT (10%)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Renal insufficiency (12%)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity reaction<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Cytokine release syndrome (94%), hypogammaglobulinemia (15%), unspecified pathogen infections, viral infections, bacterial infections, histiocytosis hematophagic</p><p><b>Common</b> (1% to 10%): Fungal infections<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Yescarta (axicabtagene ciloleucel)." Kite Pharma, Inc., El Segundo, CA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the cost of Yescarta?</li>
<li>How is Yescarta administered?</li>
<li>What type of drug is Yescarta (axicabtagene ciloleucel)?</li>
</ul><h2>More about axicabtagene ciloleucel</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Axicabtagene ciloleucel Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>B Cell Lymphoma</li>
<li>Diffuse Large B-Cell Lymphoma</li>
<li>Follicular Lymphoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>